Sister Vaccinology Networks

The Global Challenges Research Fund (GCRF) funded five vaccine networks, which were established in 2017 and included BactiVac. Our members are welcome to work with people across these networks.



The Human Challenge Model (Hic-Vac) Network based at Imperial College London aims to support, develop and advocate for human infection challenge studies (HIC) to accelerate the development of vaccines against pathogens of high global impact. This Network enables open sharing of knowledge and expertise, using Network resources to increase HIC use in the UK and LMICs, disseminating best practice, enhancing training and fostering new collaborative studies relevant to high-impact pathogens.

Contact details:


Immunising pregnant women and infants (IMPRINT) Network based at the London School of Hygiene and Tropical Medicine aims to build a sustainable Network of stakeholders from basic science, immunology, vaccinology, social sciences, industry, public health, national and international policy makers, to increase protection from infection in neonates via the safe and effective use of vaccines in pregnancy and in newborns. The Network nurtures discovery and implementation science in close collaboration with sites and investigators in LMICs, including via an IMPRINT fellowship scheme.

Contact details:

International Veterinary Vaccinology Network

The International Veterinary Vaccinology (IVVN) Network, based at the Roslin Institute, University of Edinburgh, is a multidisciplinary community passionate about developing vaccines to improve animal and human health. The Network facilitates the formation of international collaborations to improve vaccine design and development for livestock and zoonotic diseases in low-and-middle income countries (LMICs). Furthermore, the International Veterinary Vaccinology Network brings together researchers from across the fields of veterinary and human vaccinology, irrespective of pathogen or species of interest, with the aim of addressing key bottlenecks that are preventing vaccine development for important pathogens of livestock in LMICs.

Contact details:


The VALIDATE Network based at the University of Oxford promotes vaccine R&D for complex intracellular pathogens that cause significant disease burden in LMICs. The focus is on Mycobacterium tuberculosis (which causes TB), Leishmania species (leishmaniasis), Burkholderia pseudomallei (melioidosis) and Mycobacterium leprae (leprosy). The Network has created an engaged and interactive community of researchers who have formed new cross-pathogen, cross-continent, cross-species and cross-discipline collaborations, generating new ideas, taking advantage of synergies and quickly disseminating lessons learned across the Network, with the aim of together making significant progress towards vaccines against the focus pathogens. Key interests are in-vivo research, cross-pathogen studies, projects promoting the One Health agenda, and collaborative projects involving LMICs and Early Career researchers.

Contact Details: